Skip to main content

Equine Infectious Anemia Virus as a Model for Lentiviral Pathogenesis

  • Chapter
Book cover In vivo Models of HIV Disease and Control

Part of the book series: Infectious Diseases and Pathogenesis ((IAPA))

  • 504 Accesses

Abstract

Equine infectious anemia virus (EIAV), the etiologic agent of equine infectious anemia (EIA) or swamp fever, is a unique macrophage-tropic lentivirus. EIA, described in the veterinary literature in the mid-19th century, was one of the first diseases determined to be caused by a “filterable agent.” However, studies of the virus languished as methods for its culture in horse leukocytes were not described until the 1960s, and even then difficulty working with equine cultures forestalled its detailed characterization. EIAV was adapted to growth in a persistently infected cell line in 1973, and evidence that EIAV was a retrovirus was presented in 1976. A detailed characterization of viral structural proteins was finally available in the early 1980s.1 Although of considerable veterinary importance, studies of EIAV remained relatively obscure in comparison to the oncogenic retroviruses, especially those affecting more amenable animal models such as chickens and mice. EIAV and the other so-called “slow viruses” of ungulates, maedi-visna virus (MVV) of sheep and caprine-arthritis encephalitis virus (CAEV) of goats, garnered some attention due to reports that described their ability to form viral swarms during persistent infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Montelaro, R. C., Ball, J. M. and Rushlow, K. E., 1993, The Retroviridae, Plenum Press, pp. 257–360.

    Google Scholar 

  2. Maury, W., 1998, Regulation of equine infectious anemia virus expression, J. Biomed. l Sci. 5:11–23.

    Article  CAS  Google Scholar 

  3. Payne, S. L. and Elder, J. H., 2001, The role of retroviral dutpases in replication and virulence, Curr. Prot. & Pep. Sci. 2:381–388.

    Article  CAS  Google Scholar 

  4. Rice, N. R., Henderson, L. E., Sowder, R. C., Copeland, T. D., Oroszlan, S. and Edwards, J. F., 1990, Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus, J. Virol. 64:3770–3778.

    PubMed  CAS  Google Scholar 

  5. Taube, R., Fujinaga, K., Irwin, D., Wimmer, J., Geyer, M. and Peterlin, B. M., 2000, Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1, J. Virol. 74:892–898.

    Article  PubMed  CAS  Google Scholar 

  6. Li, F., Leroux, C., Craigo, J. K., Cook, S. J., Issel, C. J. and Montelaro, R. C., 2000, The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies, J. Virol. 74:573–579.

    Article  PubMed  CAS  Google Scholar 

  7. Harrold, S. M., Cook, S. J., Cook, R. F., Rushlow, K. E., Issel, C. J. and Montelaro, R. C., 2000, Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids, J. Virol. 74:3112–3121.

    Article  PubMed  CAS  Google Scholar 

  8. Oaks, J. L., Ulibarri, C. and Crawford, T. B., 1999, Endothelial cell infection in vivo by equine infectious anaemia virus, J. Gen. Virol. 80:2393–2397.

    PubMed  CAS  Google Scholar 

  9. Oaks, J. L., McGuire, T. C., Ulibarri, C. and Crawford, T. B., 1998, Equine infectious anemia virus is found in tissue macrophages during subclinical infection, J. Virol. 72:7263–7269.

    PubMed  CAS  Google Scholar 

  10. Sellon, D. C., Walker, K. M., Russell, K. E., Perry, S. T., Covington, P. and Fuller, F. J., 1996, Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses, J. Virol. 70:590–594.

    PubMed  CAS  Google Scholar 

  11. Maury, W., 1994, Monocyte maturation controls expression of equine infectious anemia virus, J. Virol. 68:6270–6279.

    PubMed  CAS  Google Scholar 

  12. Smith, T. A., Davis, E. and Carpenter, S., 1998, Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus, J. Gen. Virol. 79:747–755.

    PubMed  CAS  Google Scholar 

  13. Malmquist, W. A., Barnett, D. and Becvar, C. S., 1973, Production of equine infectious anemia antigen in a persistently infected cell line, Arch. Gesamte Virusforsch. 42:361–370.

    Article  PubMed  CAS  Google Scholar 

  14. Maury, W., Oaks, J. L. and Bradley, S., 1998, Equine endothelial cells support productive infection of equine infectious anemia virus, J. Virol. 72:9291–9297.

    PubMed  CAS  Google Scholar 

  15. Payne, S. L., La Celle, K., Pei, X. F., Qi, X. M., Shao, H., Steagall, W. K., Perry, S. and Fuller, F., 1999, Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism, J. Gen. Virol. 80:755–759.

    PubMed  CAS  Google Scholar 

  16. Cook, R. F., Issel, C. J. and Montelaro, R. C., 1996, Virus Infections of Equines, Elsevier Sciences, pp.297–323.

    Google Scholar 

  17. Sellon, D. C., Fuller, F. J. and McGuire, T. C., 1994, The immunopathogenesis of equine infectious anemia virus, Virus Res. 32:111–138.

    Article  PubMed  CAS  Google Scholar 

  18. Raabe, M. L., Issel, C. J., Cook, S. J., Cook, R. F., Woodson, B. and Montelaro, R. C., 1998, Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement, Virology 245:151–162.

    Article  PubMed  CAS  Google Scholar 

  19. Zheng, Y. H., Sentsui, H., Nakaya, T., Kono, Y. and Ikuta, K., 1997, In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: Insertions/duplications at the principal neutralizing domain, J. Virol. 71:5031–5039.

    PubMed  CAS  Google Scholar 

  20. Leroux, C., Craigo, J. K., Issel, C. J. and Montelaro, R. C., 2001, Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies, J. Virol. 75:4570–4583.

    Article  PubMed  CAS  Google Scholar 

  21. Crawford, T. B., Wardrop, K. J., Tornquist, S. J., Reilich, E., Meyers, K. M. and McGuire, T. C., 1996, A primary production deficit in the thrombocytopenia of equine infectious anemia, J. Virol. 70:7842–7850.

    PubMed  CAS  Google Scholar 

  22. Russell, K. E., Perkins, P. C., Hoffman, M. R., Miller, R. T., Walker, K. M., Fuller, F. J. and Sellon, D. C., 1999, Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional, Virology 259:7–19.

    Article  PubMed  CAS  Google Scholar 

  23. Tornquist, S. J. and Crawford, T. B., 1997, Suppression of megakaryocyte colony growth by plasma from foals infected with equine infectious anemia virus, Blood. 90:2357–2363.

    PubMed  CAS  Google Scholar 

  24. Maciejewski, J. P., Weichold, F. F., and Young, N. S., 1994, HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and tnf-alpha, J. Immunol. 153:4303–4310.

    PubMed  CAS  Google Scholar 

  25. Michelmann, I., Bèockmann, D., Nèurnberger, W., Eckhof-Donovan, S., Burdach, S. and Gèobel, U., 1997, Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man, Ann. Hematol. 74:179–184.

    Article  PubMed  CAS  Google Scholar 

  26. Tacchini-Cottier, F., Vesin, C., Redard, M., Buurman, W. and Piguet, P. F., 1998, Role of TNFR1 and TNFR2 in TNF-induced platelet consumption in mice, J. Immunol. 160:6182–6186.

    PubMed  CAS  Google Scholar 

  27. Bar, J., Zosmer, A., Hod, M., Elder, M. G. and Sullivan, M. H., 1997, The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: Changes in pregnancy and in pre-eclampsia, Thromb. Haemost. 78:1255–1261.

    PubMed  CAS  Google Scholar 

  28. Oleksowicz, L., Mrowiec, Z., Zuckerman, D., Isaacs, R., Dutcher, J. and Puszkin, E., 1994, Platelet activation induced by interleukin-6: Evidence for a mechanism involving arachidonic acid metabolism, Thromb. Haemost. 72:302–308.

    PubMed  CAS  Google Scholar 

  29. Costa, L. R., Santos, I. K., Issel, C. J. and Montelaro, R. C., 1997, Tumor necrosis factoralpha production and disease severity after immunization with enriched major core protein (p26) and/or infection with equine infectious anemia virus, Vet. Immunol. Immunopathol. 57:33–47.

    Article  PubMed  CAS  Google Scholar 

  30. Tornquist, S. J., Oaks, J. L. and Crawford, T. B., 1997, Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia, J. Gen. Virol. 78:2541–2548.

    PubMed  CAS  Google Scholar 

  31. Swardson, C. J., Lichtenstein, D. L., Wang, S., Montelaro, R. C. and Kociba, G. J., 1997, Infection of bone marrow macrophages by equine infectious anemia virus, Am. J. Vet. Res. 58:1402–1407.

    PubMed  CAS  Google Scholar 

  32. Murtaugh, M. P., Baarsch, M. J., Zhou, Y., Scamurra, R. W. and Lin, G., 1996, Inflammatory cytokines in animal health and disease, Vet. Immunol. Immunopathol. 54:45–55.

    Article  PubMed  CAS  Google Scholar 

  33. Dinarello, C. A., 1999, Cytokines as endogenous pyrogens, J. Infect. Dis. 179Suppl 2:S294–304.

    PubMed  CAS  Google Scholar 

  34. Chang, H. R., Dulloo, A. G. and Bistrian, B. R., 1998, Role of cytokines in aids wasting, Nutrition 14:853–863.

    Article  PubMed  CAS  Google Scholar 

  35. Tracey, K. J. and Cerami, A., 1994, Tumor necrosis factor: A pleiotropic cytokine and therapeutic target, Annu. Rev. Med. 45.

    Google Scholar 

  36. Means, R. T., Jr., 2000, The anaemia of infection, Baillieres Best Pract. Res. Clin. Haematol. 13:151–162.

    Article  PubMed  Google Scholar 

  37. Dinarello, C. A., 1996, Biologic basis for interleukin-1 in disease, Blood. 87:2095–2147.

    PubMed  CAS  Google Scholar 

  38. Heike, T. and Nakahata, T., 2002, Ex vivo expansion of hematopoietic stem cells by cytokines, Biochim. Biophys. Acta. 1592:313–321.

    Article  PubMed  CAS  Google Scholar 

  39. Russell, K. E., Walker, K. M., Miller, R. T. and Sellon, D. C., 1998, Hyperglobulinemia and lymphocyte subset changes in naturally infected, inapparent carriers of equine infectious anemia virus, Am. J. Vet. Res. 59:1009–1015.

    PubMed  CAS  Google Scholar 

  40. Lim, W.-S., Edwards, J. F., Boyd, N. K., Payne, S. L. and Ball, J. M., 2003, Simultaneous quantitation of equine cytokine mrnas using a multi-probe ribonuclease protection assay, Vet. Immunol. Immunopathol. 91:45–51.

    Article  PubMed  CAS  Google Scholar 

  41. Lim, W.-S., Payne, S. L., Edwards, J. F., Kim, I. and Ball, J. M., 2004, Differential effects of virulent and avirulent equine infectious anemia virus molecular clones on primary equine macrophage cytokine expression, Virology 332:295–306.

    Article  CAS  Google Scholar 

  42. Sampson, M. J., Davies, I. R., Brown, J. C., Ivory, K. and Hughes, D. A., 2002, Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients, Arterioscler Thromb Vasc Biol 22:1187–1193.

    Article  PubMed  CAS  Google Scholar 

  43. Gerencer, M., Valpotic, I., Jukic, B., Tomaskovic, M. and Basic, I., 1989, Qualitative analyses of cellular immune functions in equine infectious anemia show homology with aids, Arch. Virol. 104:249–257.

    Article  PubMed  CAS  Google Scholar 

  44. Newman, M. J., Issel, C. J., Truax, R. E., Powell, M. D., Horohov, D. W. and Montelaro, R. C., 1991, Transient suppression of equine immune responses by equine infectious anemia virus (EIAV), Virology 184:55–66.

    Article  PubMed  CAS  Google Scholar 

  45. Murakami, K., Sentsui, H., Shibahara, T. and Yokoyama, T., 1999, Reduction of CD4+ and CD8+ T lymphocytes during febrile periods in horses experimentally infected with equine infectious anemia virus, Vet. Immunol. Immunopathol. 67:131–140.

    Article  PubMed  CAS  Google Scholar 

  46. Hammond, S. A., Li, F., McKeon, B. M., Sr., Cook, S. J., Issel, C. J. and Montelaro, R. C., 2000, Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus, J. Virol. 74:5968–5981.

    Article  PubMed  CAS  Google Scholar 

  47. Howe, L., Leroux, C., Issel, C. and Montelaro, R. C., 2002, Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype, J. Virol. 76:10588–10597.

    Article  PubMed  CAS  Google Scholar 

  48. Kono, Y., Kobayashi, K. and Fukunaga, Y., 1973, Antigenic drift of equine infectious anemia virus in chronically infected horses, Arch. Gesamte Virusforsch. 41:1–10.

    Article  PubMed  CAS  Google Scholar 

  49. Leroux, C., Issel, C. J. and Montelaro, R. C., 1997, Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony, J. Virol. 71:9627–9639.

    PubMed  CAS  Google Scholar 

  50. Hammond, S. A., Cook, S. J., Lichtenstein, D. L., Issel, C. J. and Montelaro, R. C., 1997, Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process, J. Virol. 71:3840–3852.

    PubMed  CAS  Google Scholar 

  51. McGuire, T. C., Zhang, W., Hines, M. T., Henney, P. J. and Byrne, K. M., 1997, Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses, Virology 238:85–93.

    Article  PubMed  CAS  Google Scholar 

  52. Zhang, W., Lonning, S. M. and McGuire, T. C., 1998, Gag protein epitopes recognized by ELA-A-restricted cytotoxic t lymphocytes from horses with long-term equine infectious anemia virus infection, J. Virol. 72:9612–9620.

    PubMed  CAS  Google Scholar 

  53. McGuire, T. C., Tumas, D. B., Byrne, K. M., Hines, M. T., Leib, S. R., Brassfield, A. L., O’Rourke, K. I. and Perryman, L. E., 1994, Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize env and gag/pr proteins, J. Virol. 68:1459–1467.

    PubMed  CAS  Google Scholar 

  54. McGuire, T. C., Leib, S. R., Lonning, S. M., Zhang, W., Byrne, K. M. and Mealey, R. H., 2000, Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses, J. Gen. Virol. 81:2735–2739.

    PubMed  CAS  Google Scholar 

  55. Mealey, R. H., Fraser, D. G., Oaks, J. L., Cantor, G. H. and McGuire, T. C., 2001, Immune reconstitution prevents continuous equine infectious anemia virus replication in an arabian foal with severe combined immunodeficiency: Lessons for control of lentiviruses, Clin. Immunol. 101:237–247.

    Article  PubMed  CAS  Google Scholar 

  56. Hammond, S. A., Cook, S. J., Falo, L. D., Jr., Issel, C. J. and Montelaro, R. C., 1999, A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus, Virology 254:37–49.

    Article  PubMed  CAS  Google Scholar 

  57. Li, F., Craigo, J. K., Howe, L., Steckbeck, J. D., Cook, S., Issel, C. and Montelaro, R. C., 2003, A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses, J. Virol. 77:7244–7253.

    Article  PubMed  CAS  Google Scholar 

  58. Lichtenstein, D. L., Rushlow, K. E., Cook, R. F., Raabe, M. L., Swardson, C. J., Kociba, G. J., Issel, C. J. and Montelaro, R. C., 1995, Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dutpase activity, J. Virol. 69:2881–2888.

    PubMed  CAS  Google Scholar 

  59. Hammond, S. A., Raabe, M. L., Issel, C. J. and Montelaro, R. C., 1999, Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus, Virology 262:416–430.

    Article  PubMed  CAS  Google Scholar 

  60. Zheng, Y. H., Sentsui, H., Kono, Y. and Ikuta, K., 2000, Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages, Virus Res. 68:93–98.

    Article  PubMed  CAS  Google Scholar 

  61. Payne, S. L., Pei, X. F., Jia, B., Fagerness, A. and Fuller, F. J., 2004, Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus, J. Virol. 78:2478–2485.

    Article  PubMed  CAS  Google Scholar 

  62. Li, F., Puffer, B. A. and Montelaro, R. C., 1998, The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro, J. Virol. 72:8344–8348.

    PubMed  CAS  Google Scholar 

  63. Yoon, S., Kingsman, S. M., Kingsman, A. J., Wilson, S. A. and Mitrophanous, K. A., 2000, Characterization of the equine infectious anaemia virus S2 protein, J. Gen. Virol. 81:2189–2194.

    PubMed  CAS  Google Scholar 

  64. Baccam, P., Thompson, R. J., Li, Y., Sparks, W. O., Belshan, M., Dorman, K. S., Wannemuehler, Y., Oaks, J. L., Cornette, J. L. and Carpenter, S., 2003, Subpopulations of equine infectious anemia virus rev coexist in vivo and differ in phenotype, J. Virol. 77:12122–12131.

    Article  PubMed  CAS  Google Scholar 

  65. Bour, S. and Strebel, K., 2003, The HIV-1 Vpu protein: A multifunctional enhancer of viral particle release, Microbes. Infect. 5:1029–1039.

    Article  PubMed  CAS  Google Scholar 

  66. Fackler, O. T. and Baur, A. S., 2002, Live and let die: Nef functions beyond HIV replication, Immunity 16:493–497.

    Article  PubMed  CAS  Google Scholar 

  67. Chung, H. and Derse, D., 2001, Binding sites for rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA, J. Biol. Chem. 276:18960–18967.

    Article  PubMed  CAS  Google Scholar 

  68. Harris, M. E., Gontarek, R. R., Derse, D. and Hope, T. J., 1998, Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus rev protein, Mol. Cell. Biol. 18:3889–3899.

    PubMed  CAS  Google Scholar 

  69. Belshan, M., Harris, M. E., Shoemaker, A. E., Hope, T. J. and Carpenter, S., 1998, Biological characterization of rev variation in equine infectious anemia virus, J. Virol. 72:4421–4426.

    PubMed  CAS  Google Scholar 

  70. Otero, G. C., Harris, M. E., Donello, J. E. and Hope, T. J., 1998, Leptomycin B inhibits equine infectious anemia virus rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element, J. Virol. 72:7593–7597.

    PubMed  CAS  Google Scholar 

  71. Belshan, M., Park, G. S., Bilodeau, P., Stoltzfus, C. M. and Carpenter, S., 2000, Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs, Mol. Cell. Biol. 20:3550–3557.

    Article  PubMed  CAS  Google Scholar 

  72. Belshan, M., Baccam, P., Oaks, J. L., Sponseller, B. A., Murphy, S. C., Cornette, J. and Carpenter, S., 2001, Genetic and biological variation in equine infectious anemia virus rev correlates with variable stages of clinical disease in an experimentally infected pony, Virology 279:185–200.

    Article  PubMed  CAS  Google Scholar 

  73. Maury, W., Bradley, S., Wright, B. and Hines, R., 2000, Cell specificity of the transcriptionfactor repertoire used by a lentivirus: Motifs important for expression of equine infectious anemia virus in nonmonocytic cells, Virology 267:267–278.

    Article  PubMed  CAS  Google Scholar 

  74. Payne, S. L., Qi, X. M., Shao, H., Dwyer, A. and Fuller, F. J., 1998, Disease induction by virus derived from molecular clones of equine infectious anemia virus, J. Virol. 72:483–487.

    PubMed  CAS  Google Scholar 

  75. Payne, S. L., Rausch, J., Rushlow, K., Montelaro, R. C., Issel, C., Flaherty, M., Perry, S., Sellon, D. and Fuller, F., 1994, Characterization of infectious molecular clones of equine infectious anaemia virus, J. Gen. Virol. 75:425–429.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Payne, S.L., Lim, WS., Fuller, F.J., Ball, J.M. (2006). Equine Infectious Anemia Virus as a Model for Lentiviral Pathogenesis. In: Friedman, H., Specter, S., Bendinelli, M. (eds) In vivo Models of HIV Disease and Control. Infectious Diseases and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-387-25741-1_12

Download citation

Publish with us

Policies and ethics